Skip to content
Teethgrinder – Lifestyle
Author:
Vivani Medical, Inc.
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
June 25, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
June 22, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
May 28, 2026
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026